McKinsey Settles Opioid Case with $78M Payout to Insurers and Benefit Plans

McKinsey & Co. has agreed to a $78 million settlement with U.S. health insurers and benefit plans over allegations that its consulting work for drug companies, including Purdue Pharma, contributed to the opioid crisis. The settlement will establish a fund to reimburse third-party payers for opioid-related costs. McKinsey has reached several settlements related to the opioid epidemic, totaling over $900 million, but maintains that its past work was lawful. The settlement is pending judicial approval.